Massive Bio

Massive Bio is an artificial intelligence (AI)-driven platform that provides advanced oncology consulting services. It connects cancer patients and their treating oncologists with clinical trials while enabling pharmaceutical companies to access patients (primarily those in community practices) and their information to accelerate drug development. Massive Bio combines technology, services, and sub-specialty expertise in oncology to maximize trial enrollment rates. Massive Bio is the first company to tackle the control of the patient enrollment value chain; it identifies patients through both direct and indirect acquisition channels, conducts pre-screening via virtual sites, enables just-in-time (JIT) site activation, and further analyzes real-world data for drug discovery. One of Massive Bio’s key differentiators is its focus on solving the "last mile" problem of trial enrollment to eliminate location and/or financial considerations for patients. Massive Bio is the preferred partner for pharmaceutical companies and CROs to find the right patients at the right time.